… where other medicines are in shortage, pointing to greater, … FDA announced that there was a shortage of amphetamine mixed …
AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
In this issue of Deep Dive, AXON’s Silvia De Carvalho details how generative AI is ushering in a new era of expedited, data-driven clinical research, experts from Research Partnership discu
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and a wave of